The article offers an insightful look into biotech trends aimed at extending pet lifespan. It explains how interventions like rapamycin and hormonal modulation can reduce age-related diseases, with examples such as FDA-reviewed longevity pills and market data on pet supplements, making a practical case for modern veterinary care.